An economical asymmetric four step synthesis of a 2(R)-benzylsuccinic acid-4-monoamide for use as an N-terminal component in renin inhibitors has been developed (Scheme 3).
No takes yet. Share an insight, caveat, or question.
Jendralla et al. (1993) studied this question.